mefloquine has been researched along with Arthritis, Rheumatoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashikawa, K; Kodama, D; Nakamichi, K; Nishida, F; Okazaki, T; Ooka, Y; Sugiyama, Y; Tsuji, H; Yamadera, M; Yanagihara, T | 1 |
| Isozaki, E; Komori, T; Nakamichi, K; Nakata, Y; Nishigori, R; Shishido-Hara, Y; Warabi, Y | 1 |
2 other study(ies) available for mefloquine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis under salazosulfapyridine treatment].
Topics: Activities of Daily Living; Aged, 80 and over; Arthritis, Rheumatoid; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Paralysis; Sulfasalazine | 2021 |
Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Brain; CD4-CD8 Ratio; Cerebellum; Female; Humans; Immunosuppressive Agents; In Situ Hybridization; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Mefloquine; Mirtazapine; Polymerase Chain Reaction; Prognosis | 2019 |